[PYRUVIC ACID AND ALPHA-KETOGLUTARIC ACID CONTENT FOLLOWING INTRAVENOUS ADMINISTRATION OF PREDNISOLONE-SODIUM SUCCINATE].
D061605:Administration, Intravenous; D001769:Blood; D001786:Blood Glucose; D007275:Injections, Intravenous; D007656:Ketoglutaric Acids; D008660:Metabolism; D010600:Pharmacology; D011239:Prednisolone / Q000627:therapeutic use* / Q000031:analogs & derivatives; D011773:Pyruvates; D019289:Pyruvic Acid; D012964:Sodium; D013386:Succinates; D019802:Succinic Acid
D001786:Blood Glucose; D007656:Ketoglutaric Acids; D011773:Pyruvates; D013386:Succinates; D019289:Pyruvic Acid; D012964:Sodium; D011239:Prednisolone; D019802:Succinic Acid; C021322:prednisolone hemisuccinate
BLOOD; BLOOD SUGAR; INJECTIONS, INTRAVENOUS; KETOGLUTARIC ACID; METABOLISM; PHARMACOLOGY; PREDNISOLONE, THERAPEUTIC; PYRUVATES; SUCCINATES
BRENZTRAUBENSAEURE- UND ALPHA-KETOGLUTARSAEURESPIEGEL NACH INTRAVENOESER VERABREICHUNG VON PREDNISOLON-NATRIUM-SUKZINAT.